Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia

New Microbiologica

Volumn 37, Issue 1, 2014, Pages 65-73

  Abdalhamid, Baha ^a   Hassan, Hoda ^a,b   Itbaileh, Ahmad ^a   Shorman, Mahmoud ^a,c  

^a KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acinetobacter baumannii; Carbapenem resistance

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; SAUDI ARABIA; STATISTICS; TERTIARY CARE CENTER; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SAUDI ARABIA; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84894204418     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Al Johani S.M., Akhter J., Balkhy H., El-Saed A., Younan M., Memish Z. (2010). Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann. Saudi Med. 30, 364-369.
2. Al-Sweih N.A., Al-Hubail M., Rotimi V.O. (2012). Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait. J. Infect. Public. Health. 5, 102-108.
3. Al-Tawfiq J.A., Mohandhas T.X. (2007). Prevalence of antimicrobial resistance in Acinetobacter calco aceticus-baumannii complex in a Saudi Arabian hospital. Infect. Control Hosp. Epidemiol. 28, 870-872.
4. Andriamanantena T.S., Ratsima E., Rakotonirina,H.C. Randrianirina F., Ramparany L., Carod J.F., Richard V., Talarmin A. (2010). Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar. Ann. Clin. Microbiol. Antimicrob. 9, 17-0711-9-17.
5. Bannerman T.L., Hancock G.A., Tenover F.C., Miller J.M. (1995). Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33, 551-555.
6. Boo T.W., Walsh F., Crowley B. (2009). Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J. Med. Microbiol. 58, 209-216.
7. Brown S., Amyes S.G. (2005). The sequences of seven class D beta-lactamases isolated from carbapenem- resistant Acinetobacter baumannii from four continents. Clin. Microbiol. Infect. 11, 326-329.
8. Brown S., Young H.K., Amyes S.G. (2005). Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect. 11, 15-23.
9. Danel F., Paetzel M., Strynadka N.C., Page M.G. (2001). Effect of divalent metal cations on the dimerization of OXA-10 and -14 class D betalactamases from Pseudomonas aeruginosa. Biochemistry 40, 9412-9420.
10. Dijkshoorn L., van Aken E., Shunburne L., van der Reijden T.J., Bernards A.T., Nemec A., Towner K.J. (2005). Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clin. Microbiol. Infect. 11, 329-332.
11. Feizabadi M.M., Fathollahzadeh B., Taherikalani M., Rasoolinejad M., Sadeghifard N., Aligholi M., Soroush S., Mohammadi-Yegane, S. (2008). Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61, 274-278.
12. Giannouli M., Cuccurullo S., Crivaro V., Di Popolo A., Bernardo M., Tomasone F., Amato G., Brisse S., Triassi M., Utili R., Zarrilli R. (2010). Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J. Clin. Microbiol. 48, 1223-1230.
13. Grobner S., Linke D., Schutz W., Fladerer C., Madlung J., Autenrieth I.B., Witte W., Pfeifer Y. (2009). Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamaseproducing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J. Med. Microbiol. 58, 912-922.
14. Chihara S., Okuzumi K., Yamamoto Y., Oikawa S., Hishinuma A. (2011). First case of New Delhi Metallo-ß-Lactamase 1-producing Escherichia coli infection in Japan. Clin. Infect. Dis. 52, 153-154.
15. Gur D., Korten V., Unal S., Deshpande L.M., Castanheira M. (2008). Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites. J. Med. Microbiol. 57, 1529-1532.
16. Heritier C., Poirel L., Fournier P.E., Claverie J.M., Raoult D., Nordmann P. (2005). Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49, 4174-4179.
17. Ho P.L., Ho A.Y., Chow K.H., Lai E.L., Ching P., Seto W.H. (2010). Epidemiology and clonality of multidrug- resistant Acinetobacter baumannii from a healthcare region in Hong Kong. J. Hosp. Infect. 74, 358-364.
18. Khan F.Y., Abukhattab M., Baager K. (2012). Nosocomial postneurosurgical Acinetobacter baumannii meningitis: a retrospective study of six cases admitted to Hamad General Hospital, Qatar. J. Hosp. Infect. 80, 176-179.
19. Kulah C., Mooij M.J., Comert F., Aktas E., Celebi G., Ozlu N., Rijnsburger M.C., Savelkoul P.H. (2010). Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Int. J. Antimicrob. Agents 36, 114-118.
20. Maragakis L.L., Perl T.M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46, 1254-1263.
21. Memish Z.A., Shibl A.M., Kambal A.M., Ohaly Y.A., Ishaq A., Livermore D.M. (2012). Antimicrobial resistance among non-fermenting Gramnegative bacteria in Saudi Arabia. J. Antimicrob. Chemother. 67, 1701-1705.
22. Mendes R.E., Kiyota K.A., Monteiro J., Castanheira M., Andrade S.S., Gales A.C., Pignatari A.C., Tufik S. (2007). Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J. Clin. Microbiol. 45, 544-547.
23. Mugnier P., Poirel L., Pitout M., Nordmann P. (2008). Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates. Clin. Microbiol. Infect. 14, 879-882.
24. Mugnier P.D., Bindayna K.M., Poirel L., Nordmann, P. (2009). Diversity of plasmid-mediated carbapenem- hydrolysing oxacillinases among car bapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain. J. Antimicrob. Chemother. 63, 1071-1073.
25. Mugnier P.D., Poirel L., Naas T., Nordmann P. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16, 35-40.
26. Nemec A., Krizova L., Maixnerova M., Diancourt L., van der Reijden T.J., Brisse S., van den Broek P., Dijkshoorn L. (2008). Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J. Antimicrob. Chemother. 62, 484-489.
27. Park Y.S., Lee H., Lee K.S., Hwang S.S., Cho Y.K., Kim H.Y., Uh Y., Chin B.S., Han S.H., Jeong S.H., Lee K., Kim J.M. (2010). Extensively drug-resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases - a multicentre study. Int. J. Antimicrob. Agents. 36, 430-435.
28. Peleg A.Y., Seifert H., Paterson D.L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582.
29. Poirel L., Nordmann P. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12, 826-836.
30. Segal H., Elisha B.G. (2005). Use of Etest MBL strips for the detection of carbapenemases in Acinetobacter baumannii. J. Antimicrob. Chemother. 56, 598.
31. Segal H., Garny S., Elisha B.G. (2005). Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol. Lett. 243, 425-429.
32. Stoeva T., Higgins P.G., Bojkova K., Seifert H. (2008). Clonal spread of carbapenem-resistant OXA-23- positive Acinetobacter baumannii in a Bulgarian university hospital. Clin. Microbiol. Infect. 14, 723-727.
33. Tognim M.C., Andrade S.S., Silbert S., Gales A.C., Jones R.N., Sader, H.S. (2004). Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int. J. Infect. Dis. 8, 284-291.
34. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., Pitt T.L. (2006a).The role of ISAba1 in expression of OXA carbapenemasegenes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72-77.
35. Turton J.F., Woodford N., Glover J., Yarde S., Kaufmann M.E., Pitt T.L. (2006b). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976.
36. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., Amyes S.G., Livermore D.M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27, 351-353.
37. Wroblewska M.M., Towner K.J., Marchel H., Luczak M. (2007). Emergence and spread of carbapenemresistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin. Microbiol.Infect. 13, 490-496.